Complications of beta-mimetic therapy in preterm labour
- PMID: 2867757
- DOI: 10.1111/j.1479-828x.1985.tb00640.x
Complications of beta-mimetic therapy in preterm labour
Abstract
Selective beta-mimetic drugs are the most frequently used agents for arresting preterm labour. For this purpose these drugs have to be given in high doses for several hours and since they act on several organ systems, side-effects, some of which are potentially dangerous, appear. These hazards, which involve chiefly the cardiovascular and metabolic areas, have been examined in the light of available experience with these drugs. This review considers the possible mechanisms for the side-effects and offers suggestions on how the dangers in the use of beta-mimetic drugs in preterm labour might be avoided.
Similar articles
-
Ritodrine- and terbutaline-induced hypokalemia in preterm labor: mechanisms and consequences.Kidney Int. 1997 Jun;51(6):1867-75. doi: 10.1038/ki.1997.255. Kidney Int. 1997. PMID: 9186877 Clinical Trial.
-
Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.BJOG. 2001 Feb;108(2):133-42. BJOG. 2001. PMID: 11236112 Clinical Trial.
-
Cardiovascular consequences of beta-agonist tocolysis: an echocardiographic study.Obstet Gynecol. 1984 Dec;64(6):787-91. Obstet Gynecol. 1984. PMID: 6150456
-
Life-threatening complications of betamimetic therapy for preterm labor inhibition.Clin Perinatol. 1986 Dec;13(4):843-52. Clin Perinatol. 1986. PMID: 2878757 Review.
-
Preterm parturition. Beta-adrenergic agonists.Semin Perinatol. 1981 Jul;5(3):252-65. Semin Perinatol. 1981. PMID: 6116282 Review. No abstract available.
Cited by
-
Drug-induced respiratory disorders: incidence, prevention and management.Drug Saf. 2000 Aug;23(2):143-64. doi: 10.2165/00002018-200023020-00005. Drug Saf. 2000. PMID: 10945376 Review.
-
Drug-induced disorders of glucose metabolism. Mechanisms and management.Drug Saf. 1996 Aug;15(2):135-57. doi: 10.2165/00002018-199615020-00005. Drug Saf. 1996. PMID: 8884164 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical